High Quality FEMARA 2.5

Dragon Pharma manufactures Letrozole under the brand name Femara, available in a package containing 30 tablets with each tablet containing 2.5mg of the active ingredient, Letrozole.

Letrozole, initially developed as an antitumor medication, falls under the category of non-steroidal aromatase inhibitors, effectively inhibiting estrogen synthesis. This is particularly beneficial for individuals using aromatizing steroids, as it helps prevent the development of estrogen-related side effects like fat accumulation, fluid retention, and gynecomastia.

The mechanism of action of Letrozole involves selective aromatase inhibition, leading to reduced estrogen production in peripheral and tumor tissues by binding to cytochrome P450 iron. Bodybuilders and athletes often favor Letrozole due to its ability to address escalating estrogen levels at the source, its rapid tissue distribution, and its minimal impact on adrenal gland steroidogenesis and plasma androstenedione levels.

Letrozole offers advantages such as independent administration with or without meals, age-independent pharmacokinetics, and high selectivity as an aromatase inhibitor compared to other similar medications. It boasts exceptional bioavailability, quick absorption from the gastrointestinal tract, and a potency of nearly 100%.

Common side effects of Femara may include unusual sweating, nausea, diarrhea, dizziness, sleep disturbances, hot flashes, breathing difficulties, joint/muscle/bone pain, and fatigue. The recommended daily dosage of Letrozole tablets typically ranges from 1.25mg to 2.5mg, with even a small dose capable of significantly reducing circulating estrogen levels. Dosage adjustments can be made based on individual tolerance levels, with some users finding 1.25mg daily to be too potent. Due to Letrozole’s half-life of 2-4 days, dosing frequency can be adjusted to every 2-3 days to better suit individual needs. Femara 2.5 is conveniently available for purchase from our online store.